Analyst Report: Illumina Inc
All Analyst Report Argus • Jun 18, 2026 Illumina, Inc.: Raising target to $180 Summary Illumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company’s products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics
Continue Reading